HRP20080055T3 - A polymorphic form of 3-phenylsulfonyl-8-piperazin-1-yl-quinoline - Google Patents
A polymorphic form of 3-phenylsulfonyl-8-piperazin-1-yl-quinolineInfo
- Publication number
- HRP20080055T3 HRP20080055T3 HR20080055T HRP20080055T HRP20080055T3 HR P20080055 T3 HRP20080055 T3 HR P20080055T3 HR 20080055 T HR20080055 T HR 20080055T HR P20080055 T HRP20080055 T HR P20080055T HR P20080055 T3 HRP20080055 T3 HR P20080055T3
- Authority
- HR
- Croatia
- Prior art keywords
- phenylsulfonyl
- piperazin
- polymorphic form
- quinoline
- ylquinoline
- Prior art date
Links
- JJZFWROHYSMCMU-UHFFFAOYSA-N 3-(benzenesulfonyl)-8-piperazin-1-ylquinoline Chemical compound C=1N=C2C(N3CCNCC3)=CC=CC2=CC=1S(=O)(=O)C1=CC=CC=C1 JJZFWROHYSMCMU-UHFFFAOYSA-N 0.000 title abstract 2
- 238000002329 infrared spectrum Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/40—Nitrogen atoms attached in position 8
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Child & Adolescent Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0322629.7A GB0322629D0 (en) | 2003-09-26 | 2003-09-26 | Novel compound |
| PCT/EP2004/010843 WO2005040124A1 (en) | 2003-09-26 | 2004-09-23 | A polymorphic form of 3-phenylsulfonyl -8-piperazin-1-yl-quinoline |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20080055T3 true HRP20080055T3 (en) | 2008-02-29 |
Family
ID=29286934
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20080055T HRP20080055T3 (en) | 2003-09-26 | 2008-02-04 | A polymorphic form of 3-phenylsulfonyl-8-piperazin-1-yl-quinoline |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US20070032504A1 (ja) |
| EP (1) | EP1667975B1 (ja) |
| JP (1) | JP2007506702A (ja) |
| CN (1) | CN1856471A (ja) |
| AU (1) | AU2004283805A1 (ja) |
| BR (1) | BRPI0414678A (ja) |
| CA (1) | CA2540022A1 (ja) |
| CO (1) | CO5680402A2 (ja) |
| DE (1) | DE602004010410T2 (ja) |
| DK (1) | DK1667975T3 (ja) |
| ES (1) | ES2297465T3 (ja) |
| GB (1) | GB0322629D0 (ja) |
| HK (1) | HK1094190A1 (ja) |
| HR (1) | HRP20080055T3 (ja) |
| IL (1) | IL174213A0 (ja) |
| IS (1) | IS8399A (ja) |
| MA (1) | MA28093A1 (ja) |
| MX (1) | MXPA06003375A (ja) |
| NO (1) | NO20061791L (ja) |
| PL (1) | PL1667975T3 (ja) |
| PT (1) | PT1667975E (ja) |
| RU (1) | RU2355681C2 (ja) |
| WO (1) | WO2005040124A1 (ja) |
| ZA (1) | ZA200601453B (ja) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1497266E (pt) * | 2002-03-27 | 2008-09-10 | Glaxo Group Ltd | Derivados de quinolina e sua utilização como ligandos 5-ht6 |
| MXPA06000795A (es) | 2003-07-22 | 2006-08-23 | Arena Pharm Inc | Derivados de diaril y arilheteroaril urea como moduladores del receptor 5-ht2a de serotonina utiles para la profilaxis y tratamiento de desordenes relacionados con el mismo. |
| SG146658A1 (en) | 2003-09-18 | 2008-10-30 | Schering Ag | Haloalkyl containing compounds as cysteine protease inhibitors |
| CN101189208A (zh) | 2005-06-02 | 2008-05-28 | 弗·哈夫曼-拉罗切有限公司 | 作为gaba-b增强剂的3-甲磺酰基喹啉 |
| GB0519758D0 (en) * | 2005-09-28 | 2005-11-09 | Glaxo Group Ltd | Novel process |
| ES2389958T3 (es) * | 2007-03-21 | 2012-11-05 | Glaxo Group Limited | Uso de derivados de quinolina en el tratamiento del dolor |
| EP2508177A1 (en) | 2007-12-12 | 2012-10-10 | Glaxo Group Limited | Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline |
| WO2009123714A2 (en) | 2008-04-02 | 2009-10-08 | Arena Pharmaceuticals, Inc. | Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor |
| WO2010062321A1 (en) | 2008-10-28 | 2010-06-03 | Arena Pharmaceuticals, Inc. | Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related thereto |
| EP4119141A1 (en) | 2015-06-12 | 2023-01-18 | Axovant Sciences GmbH | Nelotanserin for the prophylaxis and treatment of rem sleep behavior disorder |
| CA2992518A1 (en) | 2015-07-15 | 2017-01-19 | Axovant Sciences Gmbh | Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of hallucinations associated with a neurodegenerative disease |
| CN108290842B (zh) * | 2016-05-27 | 2021-04-06 | 深圳市塔吉瑞生物医药有限公司 | 一种取代的喹啉化合物及其药物组合物 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9818916D0 (en) * | 1998-08-28 | 1998-10-21 | Smithkline Beecham Plc | Use |
| PT1497266E (pt) * | 2002-03-27 | 2008-09-10 | Glaxo Group Ltd | Derivados de quinolina e sua utilização como ligandos 5-ht6 |
| GB0321473D0 (en) * | 2003-09-12 | 2003-10-15 | Glaxo Group Ltd | Novel compounds |
-
2003
- 2003-09-26 PT PT04765655T patent/PT1667975E/pt unknown
- 2003-09-26 GB GBGB0322629.7A patent/GB0322629D0/en not_active Ceased
-
2004
- 2004-09-23 DK DK04765655T patent/DK1667975T3/da active
- 2004-09-23 US US10/572,670 patent/US20070032504A1/en not_active Abandoned
- 2004-09-23 PL PL04765655T patent/PL1667975T3/pl unknown
- 2004-09-23 ES ES04765655T patent/ES2297465T3/es active Active
- 2004-09-23 BR BRPI0414678-6A patent/BRPI0414678A/pt not_active IP Right Cessation
- 2004-09-23 RU RU2006114024/04A patent/RU2355681C2/ru active
- 2004-09-23 WO PCT/EP2004/010843 patent/WO2005040124A1/en active IP Right Grant
- 2004-09-23 CN CNA2004800275278A patent/CN1856471A/zh active Pending
- 2004-09-23 JP JP2006527373A patent/JP2007506702A/ja not_active Withdrawn
- 2004-09-23 AU AU2004283805A patent/AU2004283805A1/en not_active Abandoned
- 2004-09-23 MX MXPA06003375A patent/MXPA06003375A/es active IP Right Grant
- 2004-09-23 CA CA002540022A patent/CA2540022A1/en not_active Abandoned
- 2004-09-23 DE DE602004010410T patent/DE602004010410T2/de not_active Expired - Fee Related
- 2004-09-23 EP EP04765655A patent/EP1667975B1/en active Active
-
2006
- 2006-02-20 ZA ZA200601453A patent/ZA200601453B/en unknown
- 2006-03-09 IL IL174213A patent/IL174213A0/en unknown
- 2006-03-27 CO CO06030123A patent/CO5680402A2/es not_active Application Discontinuation
- 2006-04-05 IS IS8399A patent/IS8399A/is unknown
- 2006-04-13 MA MA28933A patent/MA28093A1/fr unknown
- 2006-04-24 NO NO20061791A patent/NO20061791L/no not_active Application Discontinuation
- 2006-11-29 HK HK06113097A patent/HK1094190A1/xx not_active IP Right Cessation
-
2008
- 2008-02-04 HR HR20080055T patent/HRP20080055T3/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1856471A (zh) | 2006-11-01 |
| CO5680402A2 (es) | 2006-09-29 |
| ES2297465T3 (es) | 2008-05-01 |
| WO2005040124A1 (en) | 2005-05-06 |
| MXPA06003375A (es) | 2006-06-08 |
| PL1667975T3 (pl) | 2008-04-30 |
| EP1667975B1 (en) | 2007-11-28 |
| GB0322629D0 (en) | 2003-10-29 |
| NO20061791L (no) | 2006-04-24 |
| AU2004283805A1 (en) | 2005-05-06 |
| MA28093A1 (fr) | 2006-08-01 |
| DE602004010410T2 (de) | 2008-10-16 |
| RU2006114024A (ru) | 2007-11-10 |
| BRPI0414678A (pt) | 2006-11-28 |
| IS8399A (is) | 2006-04-05 |
| HK1094190A1 (en) | 2007-03-23 |
| DK1667975T3 (da) | 2008-04-14 |
| EP1667975A1 (en) | 2006-06-14 |
| ZA200601453B (en) | 2007-04-25 |
| CA2540022A1 (en) | 2005-05-06 |
| PT1667975E (pt) | 2008-02-29 |
| US20070032504A1 (en) | 2007-02-08 |
| DE602004010410D1 (en) | 2008-01-10 |
| RU2355681C2 (ru) | 2009-05-20 |
| IL174213A0 (en) | 2006-08-01 |
| JP2007506702A (ja) | 2007-03-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20080055T3 (en) | A polymorphic form of 3-phenylsulfonyl-8-piperazin-1-yl-quinoline | |
| ATE509010T1 (de) | 2, 4, 6-phenylsubstituierte cyclische ketoenole | |
| CY2014041I2 (el) | 2,3-διυδρο-6-νιτροϊμιδαζο 2,1 -b-οξαζολια | |
| ATE556078T1 (de) | 2,4,6-phenylsubstituierte cyclische ketoenole | |
| CA2534569A1 (en) | Cyclic pyrazinoylguanidine sodium channel blockers | |
| HRP20070374T3 (en) | Formulations comprising ecteinascidin and a disaccharide | |
| ZA200409641B (en) | Novel substituted indoles. | |
| WO2004090145A3 (en) | Compounds and methods to enhance raav transduction | |
| TW200613256A (en) | Photoactive compounds | |
| NO20052754D0 (no) | Kaminovn, samt anvendelse av denne. | |
| DE602004024770D1 (de) | Substituierte 8-perfluoro-6,7,8,9-tetrahydropyrimido-(1,2a) pyrimidin-4-on derivate | |
| WO2005009345A3 (en) | 2-desmethyl ansamycin compounds | |
| IL175137A0 (en) | Bace455, an alternative splice variant of the human beta-secretase | |
| ZA200408738B (en) | Organic compounds. | |
| DE60315471D1 (de) | 2,5-disubstituierte 3-mercaptopentansaure | |
| EA200500878A1 (ru) | Кальцилитические соединения | |
| WO2004105780A3 (en) | Compositions comprising gastrin compounds and their use in diabetes | |
| FI20021257A0 (fi) | Vastalevyasennelma | |
| AU2003222146A1 (en) | Novel l. x formolongo lilies | |
| EP1559708A4 (en) | 1α, 25-DIHYDROXY-19-NORVITAMIN D 2,2-DISUBSTITUTED DERIVATIVE | |
| ES1052333Y (es) | Cajon premarco. | |
| SE0301847D0 (sv) | Novel 3,3-Diphenylpropylamines | |
| ITMI20031807A1 (it) | Procedimento per la preparazione di polibutadiene a contenuto variabile cis-1,4 e 1,2. | |
| IL156576A0 (en) | Communication with database by s.m.s. | |
| ES1052117Y (es) | Premarco ensamblable. |